COVID-19: ETIOLOGIA, ASPECTOS CLÍNICOS, DIAGNÓSTICO, TRATAMENTO E EPIDEMIOLOGIA

Carla Jaqueline Silva Sampaio

doi:10.22481/rsc.v16i2.6493

Autores/as

Carla Jaqueline Silva Sampaio UNIVERSIDADE FEDERAL DA BAHIA

DOI:

https://doi.org/10.22481/rsc.v16i2.6493

Palabras clave:

SARS-CoV2, COVID-19, Pandemia

Resumen

O novo coronavírus SARS-CoV2 é o agente causador da pandemia por Coronavirus Disease 2019 (COVID-19). Devido ao alcance e a gravidade da COVID-19, este trabalho objetiva realizar um levantamento das informações sobre a COVID-19, enfatizando aspectos como a patogênese, as manifestações clínicas, o diagnóstico e a epidemiologia, bem como os principais obstáculos ao enfrentamento da pandemia. Realizou-se o levantamento bibliográfico nas bases de dados MEDLINE, Biblioteca Virtual em Saúde, e PubMed utilizando palavras-chave “COVID-19”, “SARS-CoV2”, “Coronavírus”, “Síndrome respiratória” e “Gastrointestinal” nos idiomas inglês e português. A rápida transmissão do vírus tem sobrecarregado os sistemas de saúde em vários países, resultado do aumento súbito do número de casos e elevado número de óbitos. As medidas restritivas e preventivas têm sido relevantes na redução do número de casos confirmados da COVID-19. Entretanto, ainda existe a necessidade do desenvolvimento e distribuição de vacina, medicamentos e testes rápidos para melhor controle da pandemia.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Guarner J. Three emerging coronaviruses in two decades: The story of SARS, MERS, and now COVID-19. Am. J. Clin. Pathol. 2020; 153(4): 420–421. Disponível em: https://academic.oup.com/ajcp/article/153/4/420/5735509

Kong W, Agarwal PP. Chest Imaging Appearance of COVID-19 Infection. Radiology: Cardiothoracic Imaging. 2020; 2(1). Disponível em: https://pubs.rsna.org/doi/10.1148/ryct.2020200028

Velavan TP, Meyer C. The COVID-19 epidemic. Trop. Med. Int. Health. 2020; 25(3): 278-80. Disponível em: https://onlinelibrary.wiley.com/doi/10.1111/tmi.13383

Ye ZW, et al. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 2020; 16(10): 1686-1697. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32226286/

Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet. 2020; 395(10224): 542-545. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30374-3/fulltext

Lauer SA, et al. The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 2020; 172(9): 577-582. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32150748/

Chan JF, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223): 514-523. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32067043/

Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020; 158(6): 1518-1519. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32142785/

Organização Mundial da Saúde (OMS). Coronavirus disease (COVID-19) Pandemic. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/

Cai G, et al. Hint on the COVID-19 Risk: Population disparities in gene expression of three receptors of SARS-CoV. Preprints. 2020. Disponível em: https://www.preprints.org/manuscript/202002.0408/v1

Smith M, Smith JC. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. ChemRxiv. 2020. Disponível em: https://chemrxiv.org

Liu W, Li H. COVID-19 Disease: ORF8 and surface glycoprotein inhibit heme metabolism by binding to porphyrin. ChemRxiv. 2020. Disponível em: https://chemrxiv.org

Xu H, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020; 12(1): 8. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32094336/

Jia X, et al. Two things about COVID-19 might need attention. Preprints. 2020. Disponível em: https://www.preprints.org/manuscript/202002.0315/v1

Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020; 368: m1182. Disponível em: https://www.bmj.com/content/368/bmj.m1182

Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020; 8(4): e21. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32171062/

Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020; 368: m1086. Disponível em: https://www.bmj.com/content/368/bmj.m1086

Kannan S, et al. COVID-19 (Novel Coronavirus 2019) – recent trends. Eur. Rev. Med. Pharmacol. Sci. 2020; 24(4): 2006-2011. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32141569/

Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 Novel coronavirus–infected pneumonia. J. Med. Virol. 2020; 92(6): 680-682. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32124995/

Yen MY, et al. Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts. J. Microbiol. Immunol. Infect. 2020; 53(3): 377-380. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32156133/

Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol. Hepatol. 2020; 5(4): 335-337. Disponível em: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30048-0/fulltext

Sohrabi C, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int. J. Surg. 2020; 76: 71–76. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32112977/

Cheng VC, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007; 20(4): 660-694. Disponível em: https://pubmed.ncbi.nlm.nih.gov/2176051/

Peeri NC, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int. J. Epidemiol. 2020; 49(3): 717-726. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32086938/

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-1242. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32091533/

Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020; 38(1): 1-9. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32105090/

Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020; 368: m1086. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32071063/

Ai T, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1,014 cases. Radiology. 2020; 296(2): E32-E40. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32101510/

Dai W, et al. CT imaging and differential diagnosis of COVID-19. Can. Assoc. Radiol. J. 2020; 71(2): 195-200. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32129670/

Fang Y, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020; 296(2): E115-E117. Disponível em: https://pubs.rsna.org/doi/full/10.1148/radiol.2020200432

Bernheim A, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020; 295(3): 200463. Disponível em: https://pubs.rsna.org/doi/10.1148/radiol.2020200463

Xiang J, et al. Evaluation of enzyme-linked immunoassay and colloidal gold-immunochromatographic assay kit for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19). MedRxiv. 2020. Disponível em: https://www.medrxiv.org

Liu J, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020; 6: 16. Disponível em: https://www.nature.com/articles/s41421-020-0156-0

Gautret P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020; 56(1): 105949. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32205204/

Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020; 395(10231): 1225-1228. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30627-9/fulltext

Chen S, et al. COVID-19 control in China during mass population movements at New Year. Lancet. 2020; 395(10226): 764-766. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32105609/

Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19 — studies needed. N. Engl. J. Med. 2020; 382(13): 1194-1196. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32074416/

Fundação Oswaldo Cruz (FIOCRUZ). Instituto Gonçalo Muniz, Bahia. Painel Coronavírus Brasil. Disponível em: http://painel.covid19br.org/

Universidade Federal da Bahia (UFBA). Painel Coronavírus Brasil. Disponível em: http://painel.covid19br.org/

Brasil. Ministério da Saúde. Painel Coronavírus. Disponível em: https://covid.saude.gov.br/

Li R, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020; 368(6490): 489-493. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32179701/

Instituto Brasileiro de Geografia e Estatística (IBGE). Agência de Notícias. Disponível em: https://agenciadenoticias.ibge.gov.br/